Related Experiment Video
Updated: Feb 18, 2026
08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
12.0K
[Male hormonal contraception: past, present, future].
Norbert Pásztor1, Borbála Eszter Hegyi2, Attila Badó1
1Szent-Györgyi Albert Klinikai Központ, Szülészeti és Nőgyógyászati Klinika, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged, Semmelweis u. 1., 6725.
Orvosi Hetilap
|November 15, 2017
Summary
Developing male hormonal contraceptives is crucial for family planning, addressing population growth and unplanned pregnancies. Current research aims to overcome hurdles for safe and effective male birth control options.
Area of Science:
- Reproductive endocrinology
- Andrology
- Pharmacology
Background:
- Global population growth necessitates accessible family planning solutions.
- Limited contraceptive options for men contribute to unplanned pregnancies.
- Men express willingness to participate in family planning.
Purpose of the Study:
- To review the development of hormonal male contraceptives.
- To identify challenges and future directions in male contraception research.
Main Methods:
- Review of existing literature on hormonal male contraception.
- Analysis of hormonal agents targeting follicle-stimulating hormone (FSH) and luteinizing hormone (LH) suppression.
- Examination of testosterone derivatives, testosterone-progestin combinations, and synthetic androgens.
Main Results:
- Hormonal agents can suppress testosterone production and spermatogenesis.
- Various hormonal formulations have been investigated for male contraception.
- No universally safe and feasible male hormonal contraceptive is currently available.
Conclusions:
- Significant progress has been made in developing male hormonal contraceptives.
- Key challenges remain in achieving a safe and widely applicable male contraceptive.
- Future research holds promise for realizing effective male hormonal contraception.
Related Concept Videos
01:22Birth Control Methods
6.9K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
6.9K
01:21Intrauterine Drug Delivery Systems
27
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
27
01:22Hormonal Regulation of the Menstrual Cycle
1.7K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.7K
01:30Hormonal Control of the Ovarian Cycle
7.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.1K
01:24Gonadal and Placental Hormones
3.3K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
3.3K
01:28Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K